Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Manu

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
American Journal of Therapeutics|January 6, 2023
Ivermectin for COVID-19: The 2022 UpdatePeter Manu
American Journal of Therapeutics|June 6, 2023
Therapeutic Messianism: Belladonna for Heroin Withdrawal, Ivermectin for COVID-19 InfectionPeter Manu
American Journal of Therapeutics|June 6, 2023
Fatal Myocarditis After COVID-19 Vaccination: Fourteen Autopsy-Confirmed CasesPeter Manu
American Journal of Therapeutics|September 8, 2022
Liraglutide as First-Line Therapy for Type 2 Diabetics With Post-COVID-19 Fatigue Syndrome and Executive Function DeficitsPeter Manu
American Journal of Therapeutics|April 7, 2022
Repurposing Drugs for Post-COVID-19 Fatigue Syndrome: Methylphenidate, Duloxetine, and BrexpiprazolePeter Manu
The Journal of Clinical Psychiatry|November 19, 2020
Dr Manu RepliesPeter Manu
American Journal of Therapeutics|January 6, 2023
Same-Day Deaths After COVID-19 Vaccinations: Autopsy Findings in 54 CasesPeter Manu
American Journal of Therapeutics|March 22, 2024
Premature Closure of Scientific Thinking: Deaths Due to Chloroquine and Hydroxychloroquine Used for COVID-19 InfectionPeter Manu
American Journal of Therapeutics|February 10, 2023
Ivermectin and the Emergence of Long COVIDPeter Manu
American Journal of Therapeutics|February 10, 2022
Expression of Concern for Bryant a, Lawrie TA, Dowswell T, Fordham EJ, Mitchell S, Hill SR, Tham TC. Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis to Inform Clinical Guidelines. Am J Ther. 2021;28(4): e434-e460Peter Manu
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
American Journal of Therapeutics|January 6, 2023
Ivermectin for COVID-19: The 2022 UpdatePeter Manu
American Journal of Therapeutics|June 6, 2023
Therapeutic Messianism: Belladonna for Heroin Withdrawal, Ivermectin for COVID-19 InfectionPeter Manu
American Journal of Therapeutics|June 6, 2023
Fatal Myocarditis After COVID-19 Vaccination: Fourteen Autopsy-Confirmed CasesPeter Manu
American Journal of Therapeutics|September 8, 2022
Liraglutide as First-Line Therapy for Type 2 Diabetics With Post-COVID-19 Fatigue Syndrome and Executive Function DeficitsPeter Manu
American Journal of Therapeutics|April 7, 2022
Repurposing Drugs for Post-COVID-19 Fatigue Syndrome: Methylphenidate, Duloxetine, and BrexpiprazolePeter Manu
The Journal of Clinical Psychiatry|November 19, 2020
Dr Manu RepliesPeter Manu
American Journal of Therapeutics|January 6, 2023
Same-Day Deaths After COVID-19 Vaccinations: Autopsy Findings in 54 CasesPeter Manu
American Journal of Therapeutics|March 22, 2024
Premature Closure of Scientific Thinking: Deaths Due to Chloroquine and Hydroxychloroquine Used for COVID-19 InfectionPeter Manu
American Journal of Therapeutics|February 10, 2023
Ivermectin and the Emergence of Long COVIDPeter Manu
American Journal of Therapeutics|February 10, 2022
Expression of Concern for Bryant a, Lawrie TA, Dowswell T, Fordham EJ, Mitchell S, Hill SR, Tham TC. Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis to Inform Clinical Guidelines. Am J Ther. 2021;28(4): e434-e460Peter Manu
Pageof 10